111 related articles for article (PubMed ID: 32898439)
1. The Potential Usefulness of
Avan Z; Biabani Ardakani J; Talebpour Amiri F; Abedi SM; Hosseinimehr SJ
Cancer Biother Radiopharm; 2022 Nov; 37(9):862-869. PubMed ID: 32898439
[No Abstract] [Full Text] [Related]
2. Monitoring therapeutic response of human ovarian cancer to trastuzumab by SPECT imaging with (99m)Tc-peptide-Z(HER2:342).
Zhang J; Zhao X; Wang S; Wang N; Han J; Jia L; Ren X
Nucl Med Biol; 2015 Jun; 42(6):541-6. PubMed ID: 25735223
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of
Shahsavari S; Shaghaghi Z; Abedi SM; Hosseinimehr SJ
Int J Radiat Biol; 2020 Apr; 96(4):502-509. PubMed ID: 31829777
[No Abstract] [Full Text] [Related]
4. Preclinical pharmacokinetic, biodistribution, radiation dosimetry, and toxicity studies of
Biabani Ardakani J; Talebpour Amiri F; Khorramimoghaddam A; Abbasi A; Molavipordanjani S; Hosseinimehr SJ
Regul Toxicol Pharmacol; 2020 Apr; 112():104591. PubMed ID: 32006673
[TBL] [Abstract][Full Text] [Related]
5. An improved
Khodadust F; Ahmadpour S; Aligholikhamseh N; Abedi SM; Hosseinimehr SJ
Eur J Med Chem; 2018 Jan; 144():767-773. PubMed ID: 29291444
[TBL] [Abstract][Full Text] [Related]
6. Comparative assessment of a
Torabizadeh SA; Abedi SM; Noaparast Z; Hosseinimehr SJ
Bioorg Med Chem; 2017 May; 25(9):2583-2592. PubMed ID: 28351606
[TBL] [Abstract][Full Text] [Related]
7. Imaging of HER2-Positive Tumors in NOD/SCID Mice with Pertuzumab Fab-Hexahistidine Peptide Immunoconjugates Labeled with [
Facca VJ; Al-Saden N; Ku A; Reilly RM
Mol Imaging Biol; 2021 Aug; 23(4):495-504. PubMed ID: 33479914
[TBL] [Abstract][Full Text] [Related]
8. SPECT imaging of interleukin-6 receptor in ovarian tumor xenografts with a novel radiotracer of 99mTc-HYNIC-Aca-LSLITRL.
Li F; Zhang Z; Cheng T; Wei R; Dai Y; Lv M; Luo D; Zhu X; Ma D; Xi L; Dong Q; Ma X
Amino Acids; 2016 Jan; 48(1):91-101. PubMed ID: 26255282
[TBL] [Abstract][Full Text] [Related]
9. Homodimer
Ebrahimi F; Noaparast Z; Abedi SM; Hosseinimehr SJ
Med Oncol; 2022 Sep; 39(12):204. PubMed ID: 36175805
[TBL] [Abstract][Full Text] [Related]
10. Tricine co-ligand improved the efficacy of
Shaghaghi Z; Abedi SM; Hosseinimehr SJ
Biomed Pharmacother; 2018 Aug; 104():325-331. PubMed ID: 29775901
[TBL] [Abstract][Full Text] [Related]
11. The Influence of Kidneys Ion Transport Inhibitors on the Pharmacokinetic and Tumor Uptake Behaviors of a HER2-targeted Small Size Radiolabeled Peptide.
Gharibkandi NA; Molavipordanjani S; Mardanshahi A; Hosseinimehr SJ
Curr Drug Metab; 2022; 23(1):82-87. PubMed ID: 35049428
[TBL] [Abstract][Full Text] [Related]
12. SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe
Li L; Wu Y; Wang Z; Jia B; Hu Z; Dong C; Wang F
J Nucl Med; 2017 May; 58(5):821-826. PubMed ID: 28104744
[TBL] [Abstract][Full Text] [Related]
13. Diversity of RGD radiotracers in monitoring antiangiogenesis of flavopiridol and paclitaxel in ovarian cancer xenograft-bearing mice.
Yang G; Sun H; Kong Y; Hou G; Han J
Nucl Med Biol; 2014; 41(10):856-62. PubMed ID: 25195014
[TBL] [Abstract][Full Text] [Related]
14.
Rahmanian N; Hosseinimehr SJ; Khalaj A; Noaparast Z; Abedi SM; Sabzevari O
Daru; 2017 May; 25(1):13. PubMed ID: 28464952
[TBL] [Abstract][Full Text] [Related]
15. Molecular Imaging of HER2 Expression in Breast Cancer patients Using the [
Biabani Ardakani J; Abedi SM; Mardanshahi A; Shojaee L; Zaboli E; Khorramimoghaddam A; Nosrati A; Sabahno H; Banimostafavi ES; Hosseinimehr SJ
Clin Breast Cancer; 2023 Feb; 23(2):219-230. PubMed ID: 36581518
[TBL] [Abstract][Full Text] [Related]
16. Imaging and monitoring HER2 expression in breast cancer during trastuzumab therapy with a peptide probe
Wu Y; Li L; Wang Z; Shi J; Hu Z; Gao S; Miao W; Ma Q; Dong C; Wang F
Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2613-2623. PubMed ID: 32170344
[TBL] [Abstract][Full Text] [Related]
17. Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [(99m)Tc]-HYNIC-trastuzumab (Herceptin) Fab fragments.
Tang Y; Scollard D; Chen P; Wang J; Holloway C; Reilly RM
Nucl Med Commun; 2005 May; 26(5):427-32. PubMed ID: 15838425
[TBL] [Abstract][Full Text] [Related]
18. New small
Sabahnoo H; Noaparast Z; Abedi SM; Hosseinimehr SJ
Eur J Med Chem; 2017 Feb; 127():1012-1024. PubMed ID: 27842890
[TBL] [Abstract][Full Text] [Related]
19. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
[TBL] [Abstract][Full Text] [Related]
20. Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine.
Ahlgren S; Wållberg H; Tran TA; Widström C; Hjertman M; Abrahmsén L; Berndorff D; Dinkelborg LM; Cyr JE; Feldwisch J; Orlova A; Tolmachev V
J Nucl Med; 2009 May; 50(5):781-9. PubMed ID: 19372467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]